Literature DB >> 2522296

Dehydroepiandrosterone feeding prevents aortic fatty streak formation and cholesterol accumulation in cholesterol-fed rabbit.

Y Arad1, J J Badimon, L Badimon, W C Hembree, H N Ginsberg.   

Abstract

The concentration of dehydroepiandrosterone sulfate (DHEA-S) in human plasma is higher than any other steroid. Recent evidence has suggested an inverse relationship between plasma DHEA levels and the development of coronary atherosclerosis in humans. We used the cholesterol-fed rabbit model to investigate whether DHEA feeding would diminish aortic fatty streak formation in this model. Fifteen New Zealand White rabbits were fed rabbit chow supplemented with 0.5% cholesterol (wt/wt). Seven animals were, in addition, fed DHEA, 0.5% of diet (wt/wt). Animals were sacrificed after 2 months, and the aortic involvement with fatty streaks was evaluated by computerized planimetry of Sudan IV-stained aortas and by chemical analysis of aortic wall lipids. Compared to controls, DHEA-fed animals had similar plasma levels of total, very low density lipoprotein (VLDL), low density lipoprotein (LDL), and high density lipoprotein (HDL) cholesterol, corticoids, and estrogens. DHEA-fed animals had higher plasma levels of total, VLDL, and LDL triglycerides and lower HDL triglycerides than did controls. DHEA feeding resulted in 30% and 40%, respectively, inhibition of fatty streak formation by chemical analysis and planimetry. We conclude that DHEA feeding inhibits the development of aortic fatty streaks in cholesterol-fed rabbits, independent of changes in plasma total and LDL cholesterol levels of DHEA conversion to estrogens or corticoids.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2522296     DOI: 10.1161/01.atv.9.2.159

Source DB:  PubMed          Journal:  Arteriosclerosis        ISSN: 0276-5047


  18 in total

1.  Sex hormone levels and subclinical atherosclerosis in postmenopausal women: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Pamela Ouyang; Dhananjay Vaidya; Adrian Dobs; Sherita Hill Golden; Moyses Szklo; Susan R Heckbert; Peter Kopp; Susan M Gapstur
Journal:  Atherosclerosis       Date:  2008-09-06       Impact factor: 5.162

Review 2.  Gender differences in the cardiovascular effect of sex hormones.

Authors:  Cristiana Vitale; Michael E Mendelsohn; Giuseppe M C Rosano
Journal:  Nat Rev Cardiol       Date:  2009-06-30       Impact factor: 32.419

Review 3.  The biological actions of dehydroepiandrosterone involves multiple receptors.

Authors:  Stephanie J Webb; Thomas E Geoghegan; Russell A Prough; Kristy K Michael Miller
Journal:  Drug Metab Rev       Date:  2006       Impact factor: 4.518

4.  Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit.

Authors:  J J Badimon; L Badimon; V Fuster
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

5.  Adrenal androgen dehydroepiandrosterone sulfate inhibits vascular remodeling following arterial injury.

Authors:  Masaaki Ii; Masaaki Hoshiga; Nobuyuki Negoro; Ryosuke Fukui; Takahiro Nakakoji; Eiko Kohbayashi; Nobuhiko Shibata; Daisuke Furutama; Tadashi Ishihara; Toshiaki Hanafusa; Douglas W Losordo; Nakaaki Ohsawa
Journal:  Atherosclerosis       Date:  2009-02-27       Impact factor: 5.162

6.  The effect of dehydroepiandrosterone on renal ischemia-reperfusion-induced oxidative stress in rabbits.

Authors:  Yilmaz Aksoy; Turgut Yapanoglu; Hülya Aksou; A Kadir Yildirim
Journal:  Urol Res       Date:  2004-05

Review 7.  Pharmacology and therapeutic effects of dehydroepiandrosterone in older subjects.

Authors:  Sylvie Legrain; Laurence Girard
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

8.  Dehydroepiandrosterone stimulates endothelial proliferation and angiogenesis through extracellular signal-regulated kinase 1/2-mediated mechanisms.

Authors:  Dongmin Liu; Mary Iruthayanathan; Laurie L Homan; Yiqiang Wang; Lingling Yang; Yao Wang; Joseph S Dillon
Journal:  Endocrinology       Date:  2007-12-13       Impact factor: 4.736

9.  Sex-specific action of insulin to acutely increase the metabolic clearance rate of dehydroepiandrosterone in humans.

Authors:  J E Nestler; Z Kahwash
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

Review 10.  Dehydroepiandrosterone on metabolism and the cardiovascular system in the postmenopausal period.

Authors:  Caio Jordão Teixeira; Katherine Veras; Carla Roberta de Oliveira Carvalho
Journal:  J Mol Med (Berl)       Date:  2019-11-12       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.